Document is current
Any future updates will be listed below
-
Authors
He, Jianquan
He, Xingxiang
Ma, Yonghui
Yang, Luxi
Fang, Haiming
Shang, Shu
Xia, Huping
Lian, Guanghui
Tang, Hailing
Wang, Qizhi
Wang, Junping
Lin, Zhihui
Wen, Jianbo
Liu, Yuedong
Zhai, Chunbao
Wang, Wen
Jiang, Xueliang
Xuan, Ji
Liu, Morong
Lu, Shiyun
Li, Xuejun
Wang, Han
Ouyang, Cong
Cao, Man
Lin, Aiqiang
Zhang, Bangzhou
Wu, Depei
Chen, Ye
Xiao, Chuanxing https://orcid.org/0000-0002-6948-2664
-
Funding
Funding for this research was provided by:
national natural science foundation of china (81730003, 82004433)
national major science and technology projects of china (2017ZX09304021)
national office for philosophy and social sciences (16CZX064)
- License Information
-
More Information
Article History
Received: 18 July 2021
Accepted: 9 November 2021
First Online: 27 November 2021
Declarations
:
: The Ethics Committee of both Xiamen University and The First Affiliated Hospital of Clinical Medicine of Guangdong Pharmaceutical University approved the trials [NO. 2019-KY-035-02 and Ky-2019007]. The participants provided their written informed consent to participate in this study.
: Authors Han Wang, Cong Ouyang, Man Cao and Aiqiang Lin were employed by the company Xiamen Treatgut Biotechnology Co., Ltd (Xiamen, China). The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
